Pathophysiologie und Therapie der Mukoviszidose

HNO

Volumn 44, Issue 4, 1996, Pages 167-168

  Bachert, C ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; PREDNISONE;

CYSTIC FIBROSIS; HUMAN; SHORT SURVEY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; HUMANS; INFANT; MUCOCILIARY CLEARANCE; PROGNOSIS; WATER-ELECTROLYTE BALANCE;

EID: 0029945958     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Blank U, Glanz H, Eistert R, Fryen A, Lindemann H, Hüls G, Clauss W, Weber WM (1996) Benzamil und Mukoviszidose. Primärzellkullur der Nasenschleimhaut als elektrophysiologisches In-vitro-Modell. HNO 44: 172-177
2. Davidson TM, Murphy C, Mitchel M, Smith C, Light M (1995) Management of chronic sinusitis in cystic fibrosis. Laryngoscope (United States) 105: 354-358
3. Harris A (1995) Cystic fibrosis. Q J Med 88: 229-232
4. Harris CE, Wilmott RW (1994) Inhalation-based therapies in the treatment of cystic fibrosis. Curr Opin Pediatr (United States) 6: 234-238
5. Korst RJ, Mcelvaney NG, Chu CS, Rosenfeld MA, Mastrangeli A, Hay J, Brody SL, Eissa NT, Danel C, Jaffe HA, Crystal RG (1995) Gene therapy for the respiratory manifestations of cystic fibrosis. Am J Respir Crit Care Med 151: 75-87
6. Suter S (1994) New perspectives in understanding and management of the respiratory disease in cystic fibrosis. Eur J Pediatr 153: 144-150
7. Will K, Schmidtke J, Stuhrmann M (1994) Genetische Aspekte der Cystischen Fibrose. Med Genet 6: 320-324